Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SWIFT: Switching to FTC/TDF in HIV-1
NCT00724711Phase 4Completed
- Sponsor
- Gilead Sciences
- Start
- Jul 2008
- Primary completion
- Mar 2011
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 4 trial of emtricitabine + tenofovir disoproxil in human immunodeficiency virus type 1 infection (HIV-1), sponsored by Gilead Sciences. Started Jul 2008; status: completed.
02
Drugs
emtricitabine + tenofovir disoproxil
03
Conditions
human immunodeficiency virus type 1 infection (HIV-1)
Beyond the preview
Go deeper on NCT00724711.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00724711.